This stimulation can help prevent upper airway obstruction. This treatment option may be an alternative option for people who find it uncomfortable to sleep with devices on their face. Yet it also ...

"With this study, we aimed to explore the relationship between the immune system, schizophrenia and treatment resistance. Our goal was to identify immune cell changes that could potentially be ...

Sleep apnea can be treated, although a cure is not possible in many cases. Surgical treatment in children (whose bodies are still growing) often delivers positive results. Because adults live with ...

Acadia Pharmaceuticals CEO Catherine Owen Adams stated: “This application underscores our continued dedication to the Rett community, and our commitment to making a meaningful impact for people living ...

With an FDA approval submission for RegenXBio’s Hunter syndrome gene therapy already underway, the biopharma has now found a commercialization partner for both the U.S. and Asian markets.

Upper airway stimulation therapy is a new sleep apnea treatment. It’s also called hypoglossus nerve stimulation. Your doctor will put three small devices in your chest during surgery to track ...

Activated PI3K delta syndrome (APDS) is a primary immunodeficiency that is caused by mutations in ... In early 2021 (after ~8.5 months of leniolisib exposure), the proband had a ~2-month treatment gap ...

The breakthrough has been described as an "exciting step" in the fight against treatment resistance in such patients. The drug, NXP800, aims at the heat shock factor 1 (HSF1) pathway, which is a ...

tividenofusp alfa (DNL310), for the treatment of individuals with Hunter syndrome (MPS II). Denali’s wholly owned program, DNL310 or tividenofusp alfa, is an Enzyme Transport Vehicle-enabled ...

“The COVID-19 pandemic has forced EMS and all emergency providers to reassess our approach to airway management and treatment. This is especially true when we must care for patients with ...